Combining 68Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study

Combining 68Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study

BackgroundIn case of oligo-recurrent prostate cancer (PC) following prostatectomy, 68Ga-PSMA-PET/CT can be used to detect a specific site of recurrence and to initiate metastasis-directed radiation therapy (MDT). However, large heterogeneities exist concerning doses, treatment fields and radiation t...

Full description

Bibliographic Details
Main Authors: Simon Kirste, Stephanie G. C. Kroeze, Christoph Henkenberens, Nina-Sophie Schmidt-Hegemann, Marco M. E. Vogel, Jessica Becker, Constantinos Zamboglou, Irene Burger, Thorsten Derlin, Peter Bartenstein, Juri Ruf, Christian la Fougère, Matthias Eiber, Hans Christiansen, Stephanie E. Combs, Arndt-Christian Müller, Claus Belka, Matthias Guckenberger, Anca-Ligia Grosu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
metastasis-directed radiotherapy
oligorecurrent
prostate cancer
elective prostate bed radiotherapy
radiotherapy
elective nodal radiotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.640467/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.640467/full

Similar Items